Instil Bio, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $378.00K.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $71.00K.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $404.00K.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $121.00K, a 22.22% increase year-over-year.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $853.00K, a 133.70% increase from fiscal 2024.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $365.00K.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $1.76M, a 381.37% increase from fiscal 2020.
- Instil Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $365.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $853.00K 10-K · filed 2026-03-27 | |
| 2025-09-30 | $378.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $71.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $404.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $365.00K 10-K · filed 2026-03-27 | |
| 2021-12-31 | $1.76M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $121.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $1.44M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $365.00K 10-K · filed 2022-03-07 | |
| 2020-09-30 | $99.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $6.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |